Intelligent Bio Solutions Inc. (INBS) vs NeuroOne Medical Technologies Corporation (NMTC)

Intelligent Bio Solutions Inc. and NeuroOne Medical Technologies Corporation are both Medical Devices companies. NeuroOne Medical Technologies Corporation is the larger, with a market value of $7.8M against $5.8M — 1.3× the size. NeuroOne Medical Technologies Corporation grew revenue faster over the last twelve months: 42.8% against 38.1%. NeuroOne Medical Technologies Corporation has the higher net margin (−78.6% vs −294.9%) and the higher return on invested capital (−287.1% vs −606.9%). Across the 17 metrics below, NeuroOne Medical Technologies Corporation leads on 13 and Intelligent Bio Solutions Inc. on 4.

Valuation

Metric INBS NMTC Medical Devices median
P/E n/m n/m 24.94
P/S 0.70 0.78 2.66
P/B 0.55 1.95 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m n/m 11.42
EV/Sales 0.32 0.56 2.76
Earnings yield (486.87%) (109.41%) (12.66%)
Free cash flow yield (417.01%) (97.27%) (7.18%)

Profitability

Metric INBS NMTC Medical Devices median
Gross margin 48.64% 55.65% 57.76%
Operating margin (299.11%) (83.43%) (14.84%)
Net margin (294.91%) (78.63%) (14.45%)
Free cash flow margin (289.93%) (75.63%) (5.70%)
Return on equity (306.76%) (124.66%) (10.56%)
Return on assets (123.13%) (87.56%) (17.26%)
Return on invested capital (606.86%) (287.08%) (5.22%)

Growth

Metric INBS NMTC Medical Devices median
Revenue growth (TTM) 38.09% 42.83% 10.41%
EPS growth (last fiscal year) 57.80% 80.43% 28.17%
Revenue growth, 5-year CAGR 16.31% 36.40% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INBS NMTC Medical Devices median
Debt to equity 0.00 0.00 0.04
Current ratio 1.44 2.84 2.67
Net debt to EBITDA 0.35 1.74 0.54

Dividend

Metric INBS NMTC Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric INBS NMTC Medical Devices median
Market cap 5.83m 7.84m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack